LIGORIO, FRANCESCA

LIGORIO, FRANCESCA  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 20 di 21 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Cyclic fasting-mimicking diet in cancer treatment: Preclinical and clinical evidence 2024 Vernieri, ClaudioLigorio, Francesca + Article (author) -
Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitors 2023 Zattarin, EmmaMariani, LuigiLeporati, RitaProvenzano, LeonardoLigorio, FrancescaLobefaro, RiccardoVingiani, AndreaNichetti, FedericoBernocchi, OttaviaMarra, AntonioZagami, PaolaSposetti, CaterinaLosurdo, AgneseGenerali, DanieleCurigliano, GiuseppePruneri, Giancarlode Braud, FilippoVernieri, Claudio + Article (author) -
Exceptional tumour responses to fasting-mimicking diet combined with standard anticancer therapies: A sub-analysis of the NCT03340935 trial 2022 Ligorio, FrancescaProvenzano, LeonardoLobefaro, RiccardoVingiani, AndreaPruneri, Giancarlode Braud, FilippoVernieri, Claudio + Article (author) -
Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer 2022 Vernieri, ClaudioLigorio, FrancescaVingiani, AndreaIannelli, FabioRaimondi, AlessandraZanardi, FedericaAjazi, ArtaCorsetto, Paola AntoniaRizzo, Angela MariaMinucci, SaverioFoiani, MarcoPruneri, Giancarlode Braud, Filippo + Article (author) -
Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin 2022 Zattarin, EmmaNichetti, FedericoLigorio, FrancescaMazzeo, LauraLobefaro, RiccardoFuca, GiovanniPeverelli, GiorgiaVingiani, Andreade Braud, FilippoVernieri, Claudio + Article (author) -
Predictive role of CD36 expression in HER2-positive breast cancer patients receiving neoadjuvant trastuzumab 2022 Ligorio, FrancescaVerderio, PaoloCiniselli, Chiara MauraCorsetto, Paola AntoniaLorenzini, DanieleVingiani, AndreaPruneri, GiancarloVernieri, Claudio + Article (author) -
Impact of pathological stratification on the clinical outcomes of advanced well‐differentiated/dedifferentiated liposarcoma treated with trabectedin 2021 Fabbroni C.Ligorio F.Casali P. G.Sanfilippo R. + Article (author) -
Targeting lipid metabolism is an emerging strategy to enhance the efficacy of anti-HER2 therapies in HER2-positive breast cancer 2021 Ligorio F.Pellegrini I.Vingiani A.Lobefaro R.Zattarin E.Pruneri G.de Braud F.Vernieri C. + Article (author) -
Hormone receptor status influences the impact of body mass index and hyperglycemia on the risk of tumor relapse in early-stage HER2-positive breast cancer patients 2021 Ligorio F.Zambelli L.Bottiglieri A.Zattarin E.Ottini A.Vingiani A.Pruneri G.de Braud F.Vernieri C. + Article (author) -
The pan-immune-inflammation-value predicts the survival of patients with human epidermal growth factor receptor 2 (Her2)—positive advanced breast cancer treated with first-line taxane-trastuzumab-pertuzumab 2021 Ligorio F.Zattarin E.Lobefaro R.Zambelli L.Leporati R.de Braud F.Vernieri C. + Article (author) -
Impact of baseline and on-treatment glycemia on everolimus-exemestane efficacy in patients with hormone receptor-positive advanced breast cancer (EVERMET) 2021 Vernieri, ClaudioNichetti, FedericoMarra, AntonioRandon, GiovanniLigorio, FrancescaFerraro, EmanuelaTrapani, DarioMilani, AndreaBernocchi, OttaviaAjazi, ArtaGenerali, DanieleLosurdo, AgneseCurigliano, GiuseppePruneri, GiancarloMariani, Luigide Braud, Filippo + Article (author) -
Prolonged benefit from palbociclib plus letrozole in heavily pretreated advanced male breast cancer: case report 2021 Zattarin E.Ligorio F.Nichetti F.de Braud F. + Article (author) -
HER2 signaling and breast cancer stem cells: the bridge behind HER2-positive breast cancer aggressiveness and therapy refractoriness 2021 Ligorio, FrancescaTripodo, ClaudioVernieri, Claudio + Article (author) -
Prognostic role of body mass index (BMI) in patients with Human Epidermal growth factor Receptor 2 (HER2)epositive early breast cancer treated with adjuvant trastuzumab-containing chemotherapy 2020 Ligorio, F.Zambelli, L.Bottiglieri, A.Castagnoli, L.Zattarin, E.Vingiani, A.Pruneri, G.de Braud, F.Vernieri, C. + Article (author) -
Oral Capecitabine-Vinorelbine is Associated with Longer Overall Survival When Compared to Single-Agent Capecitabine in Patients with Hormone Receptor-Positive Advanced Breast Cancer 2020 Vernieri, ClaudioPrisciandaro, MicheleNichetti, FedericoLobefaro, RiccardoPeverelli, GiorgiaLigorio, FrancescaZattarin, EmmaSepe, PierangelaManglaviti, SaraPruneri, Giancarlode Braud, Filippo + Article (author) -
Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications 2020 Zattarin, ELeporati, RLigorio, FLobefaro, RVingiani, APruneri, GVernieri, C Article (author) -
Association between the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios and efficacy of CDK 4/6 inhibitors in advanced breast cancer: The observational multicenter Italian PALMARES study 2020 Zattarin, EFabbroni, CLigorio, FCorti, CBernocchi, OSirico, MCurigliano, GDe Braud, FGMVernieri, C + Article (author) -
Everolimus versus alpelisib in advanced hormone receptor-positive HER2-negative breast cancer: targeting different nodes of the PI3K/AKT/mTORC1 pathway with different clinical implications 2020 Vernieri, ClaudioNichetti, FedericoLigorio, FrancescaManglaviti, SaraZattarin, Emmade Braud, Filippo + Article (author) -
Fasting-mimicking diet plus chemotherapy in breast cancer treatment 2020 Vernieri, ClaudioLigorio, FrancescaZattarin, Emmade Braud, Filippo + Article (author) -
Antitumor activity and efficacy of shorter versus longer duration of anthracycline-taxane neoadjuvant chemotherapy in stage II-III HER2-negative breast cancer: a 10-year, retrospective analysis 2020 Lobefaro, RiccardoZattarin, EmmaNichetti, FedericoPrisciandaro, MicheleLigorio, FrancescaSepe, PierangelaPeverelli, GiorgiaOttini, AriannaBeninato, TeresaMazzeo, Laurade Braud, FilippoVernieri, Claudio + Article (author) -